1
|
Silva-Carvalho AÉ, Oliveira NND, Machado JVL, Moreira DC, Brand GD, Leite JRSA, Plácido A, Eaton P, Saldanha-Araujo F. The Peptide Salamandrin-I Modulates Components Involved in Pyroptosis and Induces Cell Death in Human Leukemia Cell Line HL-60. Pharmaceutics 2023; 15:1864. [PMID: 37514049 PMCID: PMC10384876 DOI: 10.3390/pharmaceutics15071864] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2023] [Revised: 06/26/2023] [Accepted: 06/29/2023] [Indexed: 07/30/2023] Open
Abstract
Amphibian secretions have been extensively investigated for the production of bioactive molecules. Salamandrin-I is an antioxidant peptide, isolated from the skin secretion of the fire salamander, that has induced no toxicity in microglia or erythrocytes. Importantly, the administration of antioxidants may constitute an adequate therapeutic approach to cancer treatment. Here, with the purpose of better characterizing the therapeutic potential of salamandrin-I, we investigated whether this antioxidant peptide also exerts anticancer activity, using the human leukemia cell line HL-60 as a cancer model. Salamandrin-I treatment induced a significant reduction in HL-60 proliferation, which was accompanied by cell cycle arrest. Furthermore, the peptide-induced cell death showed a significant increase in the LDH release in HL-60 cells. The cellular toxicity exerted by salamandrin-I is possibly related to pyroptosis, since the HL-60 cells showed loss of mitochondrial membrane potential and hyperexpression of inflammasome components following the peptide treatment. This is the first demonstration of the anticancer potential of the salamandrin-I peptide. Such results are important, as they offer relevant insights into the field of cancer therapy and allow the design of future bioactive molecules using salamandrin-I as a template.
Collapse
Affiliation(s)
- Amandda Évelin Silva-Carvalho
- Laboratory of Hematology and Stem Cells (LHCT), Faculty of Health Sciences, University of Brasilia, Campus Darcy Ribeiro SN, Brasilia 70910-900, Brazil
| | - Nakaly Natiely de Oliveira
- Laboratory of Hematology and Stem Cells (LHCT), Faculty of Health Sciences, University of Brasilia, Campus Darcy Ribeiro SN, Brasilia 70910-900, Brazil
| | - Julia Viana Lafetá Machado
- Laboratory of Hematology and Stem Cells (LHCT), Faculty of Health Sciences, University of Brasilia, Campus Darcy Ribeiro SN, Brasilia 70910-900, Brazil
| | - Daniel Carneiro Moreira
- Research Center in Morphology and Applied Immunology, NuPMIA, Faculty of Medicine, University of Brasilia, Campus Darcy Ribeiro SN, Brasilia 70910-900, Brazil
| | - Guilherme Dotto Brand
- Institute of Chemistry, University of Brasilia, Campus Darcy Ribeiro SN, Brasilia 70910-900, Brazil
| | - José Roberto S A Leite
- Research Center in Morphology and Applied Immunology, NuPMIA, Faculty of Medicine, University of Brasilia, Campus Darcy Ribeiro SN, Brasilia 70910-900, Brazil
| | - Alexandra Plácido
- LAQV/REQUIMTE, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal
| | - Peter Eaton
- The Bridge, School of Chemistry, University of Lincoln, Lincoln LN6 7TS, UK
| | - Felipe Saldanha-Araujo
- Laboratory of Hematology and Stem Cells (LHCT), Faculty of Health Sciences, University of Brasilia, Campus Darcy Ribeiro SN, Brasilia 70910-900, Brazil
| |
Collapse
|
2
|
Freitas GGD, Barbosa JM, Santana CJCD, Magalhães ACM, Macedo KWR, Souza JOD, Castro JSD, Vasconcelos IAD, Souza AA, Freitas SMD, Báo SN, Costa SR, Brand GD, Chaves IDM, Costa VV, Fontes W, Pires Júnior OR, Castro MS. Purification and Biological Properties of Raniseptins-3 and -6, Two Antimicrobial Peptides from Boana raniceps (Cope, 1862) Skin Secretion. Biomolecules 2023; 13:biom13030576. [PMID: 36979510 PMCID: PMC10046390 DOI: 10.3390/biom13030576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Revised: 02/20/2023] [Accepted: 02/22/2023] [Indexed: 03/30/2023] Open
Abstract
The number of multidrug-resistant pathogenic microorganisms has been growing in recent years, most of which is due to the inappropriate use of the commercial antibiotics that are currently available. The dissemination of antimicrobial resistance represents a serious global public health problem. Thus, it is necessary to search for and develop new drugs that can act as antimicrobial agents. Antimicrobial peptides are a promising alternative for the development of new therapeutic drugs. Anurans' skin glands are a rich source of broad-spectrum antimicrobial compounds and hylids, a large and diverse family of tree frogs, are known as an important source of antimicrobial peptides. In the present study, two novel antimicrobial peptides, named Raniseptins-3 and -6, were isolated from Boana raniceps skin secretion and their structural and biological properties were evaluated. Raniseptins-3 and -6 are cationic, rich in hydrophobic residues, and adopt an α-helix conformation in the presence of SDS (35 mM). Both peptides are active against Gram-negative bacteria and Gram-positive pathogens, with low hemolytic activity at therapeutic concentrations. No activity was observed for yeasts, but the peptides are highly cytotoxic against B16F10 murine melanoma cells and NIH3T3 mouse fibroblast cells. None of the tested compounds showed improvement trends in the MTT and LDH parameters of MHV-3 infected cells at the concentrations tested.
Collapse
Affiliation(s)
- Gabriel Gonçalves de Freitas
- Laboratory of Toxinology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brasilia 70.910-900, DF, Brazil
- Laboratory of Protein Chemistry and Biochemistry, Department of Cell Biology, Institute of Biological Sciences, University of Brasilia, Brasilia 70.910-900, DF, Brazil
| | - João Martins Barbosa
- Laboratory of Toxinology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brasilia 70.910-900, DF, Brazil
- Laboratory of Protein Chemistry and Biochemistry, Department of Cell Biology, Institute of Biological Sciences, University of Brasilia, Brasilia 70.910-900, DF, Brazil
| | - Carlos José Correia de Santana
- Laboratory of Toxinology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brasilia 70.910-900, DF, Brazil
- Laboratory of Protein Chemistry and Biochemistry, Department of Cell Biology, Institute of Biological Sciences, University of Brasilia, Brasilia 70.910-900, DF, Brazil
| | - Ana Carolina Martins Magalhães
- Laboratory of Toxinology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brasilia 70.910-900, DF, Brazil
| | - Keven Wender Rodrigues Macedo
- Laboratory of Toxinology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brasilia 70.910-900, DF, Brazil
| | - Jéssica Oliveira de Souza
- Laboratory of Toxinology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brasilia 70.910-900, DF, Brazil
| | - Jessica Schneider de Castro
- Laboratory of Toxinology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brasilia 70.910-900, DF, Brazil
| | - Isadora Alves de Vasconcelos
- Laboratory of Toxinology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brasilia 70.910-900, DF, Brazil
| | - Amanda Araújo Souza
- Brazilian Biosciences National Laboratory (LNBio), National Center for Research in Energy and Materials (CNPEM), Campinas 13083-970, SP, Brazil
| | - Sonia Maria de Freitas
- Laboratory of Biophysics, Department of Cell Biology, Institute of Biological Sciences, University of Brasilia, Brasilia 70.910-900, DF, Brazil
| | - Sônia Nair Báo
- Electron Microscopy Laboratory, Department of Cell Biology, Institute of Biological Sciences, University of Brasilia, Brasilia 70.910-900, DF, Brazil
| | - Samuel Ribeiro Costa
- Laboratory of Synthesis and Analysis of Biomolecules, Institute of Chemistry, University of Brasilia, Brasilia 70.910-900, DF, Brazil
| | - Guilherme Dotto Brand
- Laboratory of Synthesis and Analysis of Biomolecules, Institute of Chemistry, University of Brasilia, Brasilia 70.910-900, DF, Brazil
| | - Ian de Meira Chaves
- Center for Research and Development of Pharmaceuticals, Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270-901, MG, Brazil
| | - Vivian Vasconcelos Costa
- Center for Research and Development of Pharmaceuticals, Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270-901, MG, Brazil
| | - Wagner Fontes
- Laboratory of Protein Chemistry and Biochemistry, Department of Cell Biology, Institute of Biological Sciences, University of Brasilia, Brasilia 70.910-900, DF, Brazil
| | - Osmindo Rodrigues Pires Júnior
- Laboratory of Toxinology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brasilia 70.910-900, DF, Brazil
| | - Mariana S Castro
- Laboratory of Toxinology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brasilia 70.910-900, DF, Brazil
- Laboratory of Protein Chemistry and Biochemistry, Department of Cell Biology, Institute of Biological Sciences, University of Brasilia, Brasilia 70.910-900, DF, Brazil
| |
Collapse
|
3
|
Plácido A, do Pais do Amaral C, Teixeira C, Nogueira A, Brango-Vanegas J, Alves Barbosa E, C Moreira D, Silva-Carvalho AÉ, da Silva MDG, do Nascimento Dias J, Albuquerque P, Saldanha-Araújo F, C D A Lima F, Batagin-Neto A, Kuckelhaus S, Bessa LJ, Freitas J, Dotto Brand G, C Santos N, B Relvas J, Gomes P, S A Leite JR, Eaton P. Neuroprotective effects on microglia and insights into the structure-activity relationship of an antioxidant peptide isolated from Pelophylax perezi. J Cell Mol Med 2022; 26:2793-2807. [PMID: 35460166 PMCID: PMC9097852 DOI: 10.1111/jcmm.17292] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2021] [Revised: 02/07/2022] [Accepted: 02/22/2022] [Indexed: 11/29/2022] Open
Abstract
Tryptophyllins constitute a heterogeneous group of peptides that are one of the first classes of peptides identified from amphibian’s skin secretions. Here, we report the structural characterization and antioxidant properties of a novel tryptophyllin‐like peptide, named PpT‐2, isolated from the Iberian green frog Pelophylax perezi. The skin secretion of P. perezi was obtained by electrical stimulation and fractionated using RP‐HPLC. De novo peptide sequencing was conducted using MALDI MS/MS. The primary structure of PpT‐2 (FPWLLS‐NH2) was confirmed by Edman degradation and subsequently investigated using in silico tools. PpT‐2 shared physicochemical properties with other well‐known antioxidants. To test PpT‐2 for antioxidant activity in vitro, the peptide was synthesized by solid phase and assessed in the chemical‐based ABTS and DPPH scavenging assays. Then, a flow cytometry experiment was conducted to assess PpT‐2 antioxidant activity in oxidatively challenged murine microglial cells. As predicted by the in silico analyses, PpT‐2 scavenged free radicals in vitro and suppressed the generation of reactive species in PMA‐stimulated BV‐2 microglia cells. We further explored possible bioactivities of PpT‐2 against prostate cancer cells and bacteria, against which the peptide exerted a moderate antiproliferative effect and negligible antimicrobial activity. The biocompatibility of PpT‐2 was evaluated in cytotoxicity assays and in vivo toxicity with Galleria mellonella. No toxicity was detected in cells treated with up to 512 µg/ml and in G. mellonella treated with up to 40 mg/kg PpT‐2. This novel peptide, PpT‐2, stands as a promising peptide with potential therapeutic and biotechnological applications, mainly for the treatment/prevention of neurodegenerative disorders.
Collapse
Affiliation(s)
- Alexandra Plácido
- Department of Chemistry and Biochemistry, LAQV/REQUIMTE, Faculty of Sciences, University of Porto, Porto, Portugal
| | | | - Cátia Teixeira
- Department of Chemistry and Biochemistry, LAQV/REQUIMTE, Faculty of Sciences, University of Porto, Porto, Portugal
| | - Ariane Nogueira
- Center for Research in Applied Morphology and Immunology (NuPMIA), University of Brasilia, Brasilia, Brazil
| | - José Brango-Vanegas
- Center for Research in Applied Morphology and Immunology (NuPMIA), University of Brasilia, Brasilia, Brazil
| | - Eder Alves Barbosa
- Center for Research in Applied Morphology and Immunology (NuPMIA), University of Brasilia, Brasilia, Brazil.,Laboratory of Synthesis and Analysis of Biomolecules (LSAB), Institute of Chemistry (IQ), University of Brasilia, Brasília, Brazil
| | - Daniel C Moreira
- Center for Research in Applied Morphology and Immunology (NuPMIA), University of Brasilia, Brasilia, Brazil
| | - Amandda É Silva-Carvalho
- Laboratory of Hematology and Stem Cells, Faculty of Health Sciences, University of Brasilia, Brasília, Brazil
| | - Maria da Gloria da Silva
- Center for Research in Applied Morphology and Immunology (NuPMIA), University of Brasilia, Brasilia, Brazil
| | - Jhones do Nascimento Dias
- Department of Cell Biology, Institute of Biological Sciences, University of Brasília, Brasília, Brazil.,Biomedicine Course, Federal University of Delta do Parnaíba (UFDPar), Parnaíba, Brazil
| | - Patrícia Albuquerque
- Department of Cell Biology, Institute of Biological Sciences, University of Brasília, Brasília, Brazil.,Faculty of Ceilândia, University of Brasilia, Brasilia, Brazil
| | - Felipe Saldanha-Araújo
- Laboratory of Hematology and Stem Cells, Faculty of Health Sciences, University of Brasilia, Brasília, Brazil
| | - Filipe C D A Lima
- Federal Institute of Education, Science and Technology of São Paulo, Matão, Brazil
| | | | - Selma Kuckelhaus
- Center for Research in Applied Morphology and Immunology (NuPMIA), University of Brasilia, Brasilia, Brazil
| | - Lucinda J Bessa
- Department of Chemistry and Biochemistry, LAQV/REQUIMTE, Faculty of Sciences, University of Porto, Porto, Portugal.,Egas Moniz Interdisciplinary Research Center (CiiEM), Egas Moniz - Cooperative for Higher Education, CRL, Almada, Portugal
| | - Jaime Freitas
- Institute for Research and Innovation in Health (i3S), National Institute of Biomedical Engineering (INEB), University of Porto, Porto, Portugal
| | - Guilherme Dotto Brand
- Laboratory of Synthesis and Analysis of Biomolecules (LSAB), Institute of Chemistry (IQ), University of Brasilia, Brasília, Brazil
| | - Nuno C Santos
- Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
| | - João B Relvas
- Institute for Research and Innovation in Health (i3S), Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal
| | - Paula Gomes
- Department of Chemistry and Biochemistry, LAQV/REQUIMTE, Faculty of Sciences, University of Porto, Porto, Portugal
| | - José Roberto S A Leite
- Department of Chemistry and Biochemistry, LAQV/REQUIMTE, Faculty of Sciences, University of Porto, Porto, Portugal.,Center for Research in Applied Morphology and Immunology (NuPMIA), University of Brasilia, Brasilia, Brazil
| | - Peter Eaton
- Department of Chemistry and Biochemistry, LAQV/REQUIMTE, Faculty of Sciences, University of Porto, Porto, Portugal.,The Bridge, School of Chemistry, Joseph Banks Laboratories, University of Lincoln, Lincoln, UK
| |
Collapse
|
4
|
Barbosa EA, Alves GSC, Coura MDMA, Silva HDLE, Rocha FSD, Nunes JB, Watanabe MDS, Andrade AC, Brand GD. A first look at the N- and O-glycosylation landscape in anuran skin secretions. Biochimie 2022; 197:19-37. [DOI: 10.1016/j.biochi.2022.01.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2021] [Revised: 01/08/2022] [Accepted: 01/17/2022] [Indexed: 11/26/2022]
|
5
|
Caetano-Silva ME, Simabuco FM, Bezerra RMN, da Silva DC, Barbosa EA, Moreira DC, Brand GD, Leite JRDSDA, Pacheco MTB. Isolation and Sequencing of Cu-, Fe-, and Zn-Binding Whey Peptides for Potential Neuroprotective Applications as Multitargeted Compounds. J Agric Food Chem 2020; 68:12433-12443. [PMID: 33095576 DOI: 10.1021/acs.jafc.0c03647] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
This study aims to isolate metal-binding peptides and synthesize promising amino acid sequences to potentially act as neuroprotective compounds in the future, targeting different mechanisms. Fractions of whey metal-binding peptides (Cu, Fe, and Zn) isolated by immobilized metal affinity chromatography showed different amino acid profiles according to the metal. The Cu-binding peptides presented roughly twofold increase in the in vitro antioxidant, as assessed by oxygen radical absorbance capacity and anticholinesterase activities over the hydrolysate. This is probably because of the higher concentration of aromatic and basic residues, the latter being crucial for binding to the anionic sites of acetylcholinesterase. Six peptide sequences were synthesized based on the metal-binding sites, molecular mass, hydrophobicity, and bioactivity probability. Among the synthetic peptides, the VF dipeptide stood out both for its in vitro antioxidant and anticholinesterase activities. This peptide, as well as the fraction of Cu-binding peptides, should be further studied because it may act through different mechanisms related to neurodegenerative diseases, in addition to the chelation of the excess of metals in the central nervous system.
Collapse
Affiliation(s)
- Maria Elisa Caetano-Silva
- Center of Food Science and Quality, CCQA, Institute of Food Technology, ITAL, Campinas, 13070-178 Campinas, Brazil
| | - Fernando Moreira Simabuco
- Multidisciplinary Laboratory of Food and Health, LABMAS, School of Applied Sciences, FCA, University of Campinas, UNICAMP, Limeira, 13484-350 Limeira, Brazil
| | - Rosângela Maria Neves Bezerra
- Multidisciplinary Laboratory of Food and Health, LABMAS, School of Applied Sciences, FCA, University of Campinas, UNICAMP, Limeira, 13484-350 Limeira, Brazil
| | - Daniele Cristina da Silva
- Center of Food Science and Quality, CCQA, Institute of Food Technology, ITAL, Campinas, 13070-178 Campinas, Brazil
| | - Eder Alves Barbosa
- Laboratory for the Synthesis and Analysis of Biomolecules, Institute of Chemistry, IQ, University of Brasília, Brasília, 70910-900 Distrito Federal, Brazil
- Research Center in Morphology and Applied Immunology, NuPMIA, Morphology Area, Faculty of Medicine, University of Brasília, UnB, Brasília, 70910-900 Distrito Federal, Brazil
| | - Daniel Carneiro Moreira
- Research Center in Morphology and Applied Immunology, NuPMIA, Morphology Area, Faculty of Medicine, University of Brasília, UnB, Brasília, 70910-900 Distrito Federal, Brazil
| | - Guilherme Dotto Brand
- Laboratory for the Synthesis and Analysis of Biomolecules, Institute of Chemistry, IQ, University of Brasília, Brasília, 70910-900 Distrito Federal, Brazil
| | - José Roberto de Souza de Almeida Leite
- Research Center in Morphology and Applied Immunology, NuPMIA, Morphology Area, Faculty of Medicine, University of Brasília, UnB, Brasília, 70910-900 Distrito Federal, Brazil
| | | |
Collapse
|
6
|
Barbosa EA, Fontes NDC, Santos SCL, Lefeber DJ, Bloch C, Brum JM, Brand GD. Relative quantification of plasma N-glycans in type II congenital disorder of glycosylation patients by mass spectrometry. Clin Chim Acta 2019; 492:102-113. [PMID: 30776362 DOI: 10.1016/j.cca.2019.02.013] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2018] [Revised: 02/12/2019] [Accepted: 02/13/2019] [Indexed: 01/06/2023]
Abstract
BACKGROUND Type II Congenital Disorders of Glycosylation (CDG-II) are a group of diseases with challenging diagnostics characterized by defects in the processing of glycans in the Golgi apparatus. Mass Spectrometry (MS) has been a valuable tool in the definition of CDG-II subtypes. While some CDG-II subtypes are associated with specific N-glycan structures, others only produce changes in relative levels, reinforcing the demand for quantification methods. METHODS Plasma samples from control individuals were pooled, derivatized with deuterated iodomethane (I-CD3), and used as internal standards for controls and patients whose glycans were derivatized with iodomethane (I-CH3), followed by MALDI MS, LC-MS and -MS/MS analyses. RESULTS Total N-glycans from fifteen CDG-II patients were evaluated, and 4 cases with molecular diagnosis were considered in detail: 2ATP6V0A2-CDG siblings, and 2 MAN1B1-CDG patients, one of them carrying a previously undescribed p.Gly536Val mutation. CONCLUSIONS Our methodology offers a feasible alternative to the current methods for CDG-II diagnosis by MS, which quantify glycan structures as fractions of the total summed signal across a mass spectrum, a strategy that lowers the variability of minor components. Moreover, given its sensitivity for less concentrated yet biologically relevant structures, it might assist the uncovering of novel diagnostic glycans in other CDG-II subtypes.
Collapse
Affiliation(s)
- E A Barbosa
- Laboratório de Síntese e Análise de Biomoléculas - LSAB, Instituto de Química - IQ, Universidade de Brasília - UnB, Brasília, DF, Brazil; Laboratório de Espectrometria de Massa - LEM, Embrapa Recursos Genéticos e Biotecnologia, Brasília, DF, Brazil
| | - N do C Fontes
- Laboratório de Genética Bioquímica, Rede Sarah de Hospitais de Reabilitação, Brasília, DF, Brazil
| | - S C L Santos
- Laboratório de Biologia Molecular, Rede Sarah de Hospitais de Reabilitação, Brasília, DF, Brazil
| | - D J Lefeber
- Department of Neurology, Translational Metabolic Laboratory, Donders Center for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands
| | - C Bloch
- Laboratório de Espectrometria de Massa - LEM, Embrapa Recursos Genéticos e Biotecnologia, Brasília, DF, Brazil
| | - J M Brum
- Laboratório de Genética Bioquímica, Rede Sarah de Hospitais de Reabilitação, Brasília, DF, Brazil
| | - G D Brand
- Laboratório de Síntese e Análise de Biomoléculas - LSAB, Instituto de Química - IQ, Universidade de Brasília - UnB, Brasília, DF, Brazil.
| |
Collapse
|
7
|
Brand GD, Ramada MHS, Genaro-Mattos TC, Bloch C. Towards an experimental classification system for membrane active peptides. Sci Rep 2018; 8:1194. [PMID: 29352252 PMCID: PMC5775428 DOI: 10.1038/s41598-018-19566-w] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2017] [Accepted: 01/05/2018] [Indexed: 11/17/2022] Open
Abstract
Mature proteins can act as potential sources of encrypted bioactive peptides that, once released from their parent proteins, might interact with diverse biomolecular targets. In recent work we introduced a systematic methodology to uncover encrypted intragenic antimicrobial peptides (IAPs) within large protein sequence libraries. Given that such peptides may interact with membranes in different ways, resulting in distinct observable outcomes, it is desirable to develop a predictive methodology to categorize membrane active peptides and establish a link to their physicochemical properties. Building upon previous work, we explored the interaction of a range of IAPs with model membranes probed by differential scanning calorimetry (DSC) and circular dichroism (CD) techniques. The biophysical data were submitted to multivariate statistical methods and resulting peptide clusters were correlated to peptide structure and to their antimicrobial activity. A re-evaluation of the physicochemical properties of the peptides was conducted based on peptide cluster memberships. Our data indicate that membranolytic peptides produce characteristic thermal transition (DSC) profiles in model vesicles and that this can be used to categorize novel molecules with unknown biological activity. Incremental expansion of the model presented here might result in a unified experimental framework for the prediction of novel classes of membrane active peptides.
Collapse
Affiliation(s)
- G D Brand
- Laboratório de Espectrometria de Massa, Embrapa Recursos Genéticos e Biotecnologia, Brasília, DF, Brazil.,Laboratório de Síntese e Análise de Biomoléculas, Instituto de Química, Universidade de Brasília, Brasília, DF, Brazil
| | - M H S Ramada
- Laboratório de Espectrometria de Massa, Embrapa Recursos Genéticos e Biotecnologia, Brasília, DF, Brazil.,Departamento de Biologia Celular, Instituto de Ciências Biológicas, Universidade de Brasília, Brasília, DF, Brazil.,Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, DF, Brazil
| | | | - C Bloch
- Laboratório de Espectrometria de Massa, Embrapa Recursos Genéticos e Biotecnologia, Brasília, DF, Brazil.
| |
Collapse
|
8
|
Ramada MHS, Brand GD, Abrão FY, Oliveira M, Filho JLC, Galbieri R, Gramacho KP, Prates MV, Bloch C. Encrypted Antimicrobial Peptides from Plant Proteins. Sci Rep 2017; 7:13263. [PMID: 29038449 PMCID: PMC5643462 DOI: 10.1038/s41598-017-13685-6] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2017] [Accepted: 09/26/2017] [Indexed: 12/26/2022] Open
Abstract
Examples of bioactive peptides derived from internal sequences of proteins are known for decades. The great majority of these findings appear to be fortuitous rather than the result of a deliberate and methodological-based enterprise. In the present work, we describe the identification and the biological activities of novel antimicrobial peptides unveiled as internal fragments of various plant proteins founded on our hypothesis-driven search strategy. All putative encrypted antimicrobial peptides were selected based upon their physicochemical properties that were iteratively selected by an in-house computer program named Kamal. The selected peptides were chemically synthesized and evaluated for their interaction with model membranes. Sixteen of these peptides showed antimicrobial activity against human and/or plant pathogens, some with a wide spectrum of activity presenting similar or superior inhibition efficacy when compared to classical antimicrobial peptides (AMPs). These original and previously unforeseen molecules constitute a broader and undisputable set of evidences produced by our group that illustrate how the intragenic concept is a workable reality and should be carefully explored not only for microbicidal agents but also for many other biological functions.
Collapse
Affiliation(s)
- M H S Ramada
- Laboratório de Espectrometria de Massa, Embrapa Recursos Genéticos e Biotecnologia, 70770-917, Brasília, DF, Brazil
- Departamento de Biologia Celular, Instituto de Ciências Biológicas, Universidade de Brasília, 70910-900, Brasília, DF, Brazil
- Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, 70790-160, Brasília, DF, Brazil
| | - G D Brand
- Laboratório de Síntese e Análise de Biomoléculas, Instituto de Química, Universidade de Brasília, Brasília, DF, Brazil
| | - F Y Abrão
- Faculdade de Farmácia, FacUnicamps, 74535-280, Goiânia, GO, Brazil
| | - M Oliveira
- Faculdade de Farmácia, FacUnicamps, 74535-280, Goiânia, GO, Brazil
| | - J L Cardozo Filho
- Laboratório de Espectrometria de Massa, Embrapa Recursos Genéticos e Biotecnologia, 70770-917, Brasília, DF, Brazil
- Departamento de Fitopatologia, Instituto Mato-Grossense do Algodão, 78850-000, Primavera do Leste, MT, Brazil
| | - R Galbieri
- Departamento de Fitopatologia, Instituto Mato-Grossense do Algodão, 78850-000, Primavera do Leste, MT, Brazil
| | - K P Gramacho
- Laboratório de Fitopatologia Molecular, Centro de Pesquisa do Cacau, 45600-970, Itabuna, BA, Brazil
| | - M V Prates
- Laboratório de Espectrometria de Massa, Embrapa Recursos Genéticos e Biotecnologia, 70770-917, Brasília, DF, Brazil
| | - C Bloch
- Laboratório de Espectrometria de Massa, Embrapa Recursos Genéticos e Biotecnologia, 70770-917, Brasília, DF, Brazil.
| |
Collapse
|
9
|
Brand GD, Matos HCD, Cruz GCND, Fontes NDC, Buzzi M, Brum JM. Diagnosing lysosomal storage diseases in a Brazilian non-newborn population by tandem mass spectrometry. Clinics (Sao Paulo) 2013; 68:1469-73. [PMID: 24270961 PMCID: PMC3812554 DOI: 10.6061/clinics/2013(11)14] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/22/2013] [Accepted: 08/02/2013] [Indexed: 11/18/2022] Open
Abstract
OBJECTIVES High-throughput mass spectrometry methods have been developed to screen newborns for lysosomal storage disorders, allowing the implementation of newborn screening pilot studies in North America and Europe. It is currently feasible to diagnose Pompe, Fabry, Gaucher, Krabbe, and Niemann-Pick A/B diseases, as well as mucopolysaccharidosis I, by tandem mass spectrometry in dried blood spots, which offers considerable technical advantages compared with standard methodologies. We aimed to investigate whether the mass spectrometry methodology for lysosomal storage disease screening, originally developed for newborns, can also discriminate between affected patients and controls of various ages. METHODS A total of 205 control individuals were grouped according to age and subjected to mass spectrometry quantification of lysosomal α-glucosidase, β-glucocerebrosidase, α-galactosidase, acid sphingomyelinase, galactocerebrosidase, and α-L-iduronidase activities. Additionally, 13 affected patients were analyzed. RESULTS The median activities for each enzyme and each age group were determined. Enzyme activities were significantly lower in individuals aged older than 18 years compared with those in newborns. Affected patients presented enzymatic activities corresponding to less than 20% of the age-matched controls. CONCLUSIONS Our data indicate that the mass spectrometry methodology can be used for the screening of lysosomal storage diseases in non-newborn patients. However, for some diseases, such as Fabry and mucopolysaccharidosis I, a combination of biochemical and clinical data may be necessary to achieve accurate diagnoses.
Collapse
Affiliation(s)
- Guilherme Dotto Brand
- Laboratório de Genética Bioquímica, Rede Sarah de Hospitais de Reabilitação, BrasíliaDF, Brazil
| | | | | | | | | | | |
Collapse
|
10
|
Carvalho DR, Brand GD, Brum JM, Takata RI, Speck-Martins CE, Pratesi R. Analysis of novel ARG1 mutations causing hyperargininemia and correlation with arginase I activity in erythrocytes. Gene 2012; 509:124-30. [PMID: 22959135 DOI: 10.1016/j.gene.2012.08.003] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2012] [Revised: 07/06/2012] [Accepted: 08/01/2012] [Indexed: 02/09/2023]
Abstract
Hyperargininemia (HA) is an autosomal recessive disease that typically has a clinical presentation that is distinct from other urea cycle disorders. It is caused by the deficient activity of the enzyme arginase I, encoded by the gene ARG1. We screened for ARG1 mutations and measured erythrocyte enzyme activity in a series of 16 Brazilian HA patients. Novel mutations, in addition to previously described missense mutations, were analysed for their effect on the structure, stability and/or function of arginase I (ARG1) using bioinformatics tools. Three previously reported mutations were found (p.R21X; p.I11T and p.W122X), and five novel mutations were identified (p.G27D; p.G74V; p.T134I; p.R308Q; p.I174fs179). The p.T134I mutation was the most frequent in the Brazilian population. Patients carrying the p.R308Q mutation had higher residual ARG1 decreased activity, but presented no distinguishable phenotype compared to the other patients. Bioinformatics analyses revealed that missense mutations (1) affect the ARG1 active site, (2) interfere with the stability of the ARG1 folded conformation or (3) alter the quaternary structure of the ARG1. Our study reinforced the role of Arg308 residue for assembly of the ARG1 homotrimer. The panel of heterogeneous ARG1 mutations that cause HA was expanded, nevertheless a clear genotype-phenotype correlation was not observed in our series.
Collapse
Affiliation(s)
- Daniel Rocha Carvalho
- Genetic Unit, SARAH Rehabilitation Hospital, SMHS Quadra 501 Conj. A, Brasilia, Distrito Federal, 70335-901, Brazil.
| | | | | | | | | | | |
Collapse
|
11
|
Brand GD, Krause FC, Silva LP, Leite JRSA, Melo JAT, Prates MV, Pesquero JB, Santos EL, Nakaie CR, Costa-Neto CM, Bloch C. Bradykinin-related peptides from Phyllomedusa hypochondrialis. Peptides 2006; 27:2137-46. [PMID: 16797783 DOI: 10.1016/j.peptides.2006.04.020] [Citation(s) in RCA: 48] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/02/2006] [Revised: 04/11/2006] [Accepted: 04/11/2006] [Indexed: 11/28/2022]
Abstract
Bradykinin related peptides (BRPs) present in the water-soluble secretion and freshly dissected skin fragments of Phyllomedusa hypochondrialis were investigated by mass spectrometry techniques. Eighteen BRPs, along with their post-translational modifications, were characterized in the secretion by de novo MS/MS sequencing and direct MALDI imaging experiments of the frog skin. These molecules revealed strong sequence similarities to the main plasma kinin of some mammals and reptiles. Such a diversity of molecules, within the same peptide family, belonging to a single amphibian species may be related to functional specializations of these peptides and a variety of corresponding receptors that might be present in a number of different predators. Also, a novel analog, [Val]1,[Thr]6-bradykinyl-Gln,Ser had its biological activity positively detected in cell culture expressing the human bradykinin B2 receptor and in guinea pig ileum preparations.
Collapse
Affiliation(s)
- G D Brand
- Laboratório de Espectrometria de Massa, EMBRAPA, Recursos Genéticos e Biotecnologia, Brasília, DF 70770-900, Brazil
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|